Parkinson's Disease (PD)

About Parkinson's Disease (PD)

Parkinson's Disease (PD) is a progressive neurodegenerative disorder of the central nervous system that primarily impacts the brain's motor control systems, leading to involuntary movements, stiffness, and difficulty with balance and coordination.

While most widely recognized for its characteristic motor symptoms, Parkinson's is a complex multisystem condition that affects both motor and non-motor functions across four key areas:

Primary Motor Symptoms: Tremor at rest (often starting in one hand or foot), bradykinesia (slowness of movement), muscle rigidity or stiffness, and postural instability leading to balance problems and gait changes (e.g., shuffling steps, reduced arm swing).

Secondary Motor Features: Impaired fine motor skills, reduced facial expression (facial masking), softer or slurred speech (hypophonia), difficulty swallowing, and micrographia (abnormally small handwriting).

Autonomic & Non-Motor Symptoms: Autonomic dysregulation leading to chronic constipation, orthostatic hypotension (blood pressure drops upon standing), sleep disturbances (such as REM Sleep Behavior Disorder), and loss of smell (anosmia).

Cognitive & Neuropsychiatric Shifts: Changes in executive function, slowed cognitive processing speed, anxiety, apathy, depression, and, in advanced stages, potential cognitive decline or dementia. A progressive neurodegenerative movement disorder that primarily affects dopamine-producing neurons in a specific region of the brain called the substantia nigra. Dopamine acts as a chemical messenger responsible for transmitting signals that coordinate smooth, purposeful muscle movements. As these neurons die, movement control degrades, and non-motor neurological symptoms emerge.

Current leading research indicates that many neurodegenerative diseases may be heavily influenced by lifestyle and environmental factors including chronic inflammation, toxin exposure, nutritional and hormonal deficits, metabolic dysfunction, physical / emotional trauma, and vascular issues.

Frequency: Nearly 1 million people are currently living with Parkinson’s disease (PD) in the United States. This represents a baseline prevalence of roughly 1 out of every 336 people, with expectations that the total will surpass 1.2 million cases by 2030 as the population ages. Approximately 90,000 new cases are diagnosed in the U.S. every year. Comprehensive epidemiological data revealed a 50% spike from earlier baseline estimates of 60,000 annual diagnoses. It is the second most common age-related neurodegenerative disorder in America, trailing only Alzheimer's disease.

Age Distribution: Advanced age is the primary risk factor. Only 4% of individuals are diagnosed before age 50. The prevalence rate sits around 1% at age 60 and sharpens to roughly 4% by age 80.

Gender Differences: Men are 1.5 times more likely to be diagnosed with Parkinson's than women across all age groups.

Types and classifications

• Conventional neurologists often use four basic categories to define the types of PD, Idiopathic PD, which is the classic form, Early-Onset, Atypical, and Secondary. Additional subtypes are categorized by physical phenotypes, such as tremor-dominant versus postural instability and gait dysfunction.
• Idiopathic Parkinson’s Disease: The classic form with no identifiable cause. It accounts for the majority of cases and is characterized by the progressive loss of dopamine-producing neurons in the substantia nigra. Symptoms usually begin after age 60 and progress gradually.
• Early-Onset Parkinson’s Disease: Symptoms appear before age 50 (sometimes in the 30s or 40s). It often has a stronger genetic component (e.g., LRRK2, PARKIN, PINK1, SNCA) and may progress more slowly than late-onset forms, though it can have a greater impact on quality of life due to longer disease duration. Not all carriers develop PD, as lifestyle and environmental factors play a major role.
• Atypical Parkinsonism (Parkinson-Plus Syndromes): A group of neurodegenerative disorders (such as Progressive Supranuclear Palsy or Multiple System Atrophy) that mimic Parkinson's early symptoms but involve different brain pathologies, progress faster, and respond poorly to standard medications.
• Secondary Parkinsonism: Parkinson's-like symptoms that are explicitly caused by external factors rather than primary degeneration, such as side effects from certain antipsychotic medications (Drug-induced), repeated head trauma, or multiple small strokes affecting movement centers (Vascular Parkinsonism).
• Functional practitioners categorize Parkinson's disease based on where alpha-synuclein misfolding originates, as well as the specific environmental or systemic factors damaging dopamine-producing cells. High-level classifications center on three primary domains: Origin Subtypes, which distinguish between "gut-first" and "brain-first" pathways; Metabolic and Toxic Subtypes, which pinpoint specific biochemical root causes like neurotoxins, mitochondrial burnout, or insulin resistance; and Motor System Asymmetry, which evaluates how hemispheric imbalances and communication breakdowns between brain networks drive motor symptoms.
• Origin Subtypes: "Gut-First" vs. "Brain-First": Based on the Braak Hypothesis, this category differentiates Parkinson’s by where the initial damage begins. "Gut-First" originates in the enteric nervous system, where dysbiosis drives misfolded proteins up the vagus nerve to the brain stem, causing early symptoms like chronic constipation, smell loss, and sleep disorders. "Brain-First" originates directly in the central nervous system—often triggered by blood-brain barrier breaches or inhaled toxins—causing cognitive decline or mood changes to present alongside or before motor issues.
• Metabolic and Toxic Subtypes: This categorization groups Parkinson’s by specific biochemical root causes to guide targeted functional treatments. The Toxic/Pesticide Type is driven by heavy environmental neurotoxins or metals that target and destroy substantia nigra cells. The Mitochondrial/Cellular Burnout Type stems from cellular energy failure and oxidative stress, while the "Glycative" (Metabolic) Type is caused by insulin resistance and high blood sugar damaging dopamine receptors and brain tissue.
• Functional Neurology Lens: Motor System Asymmetry: This framework evaluates Parkinson’s by examining brain asymmetry and pathway communication. The Basal Ganglia Pathway Type involves an imbalance between movement's accelerator (direct pathway) and brake (indirect pathway), leading to rigidity, shuffling gait, and a masked face when dopamine drops. The Cerebellar-Imbalance Type traces severe resting tremors and postural instability to a timing breakdown between the basal ganglia and the cerebellum, which is treated through targeted visual and coordination exercises.

Symptoms associated in the NPA database

The NPA Treatment Database groups the following symptom information with Parkinson's Disease (PD). This list is educational and is not a diagnostic checklist.

Treatment information in the database

The NPA Treatment Database lists 27 treatment records in connection with Parkinson's Disease (PD). A database relationship does not establish that a treatment is effective, safe, or appropriate for any individual.

• Adaptive or Closed-Loop Deep Brain Stimulation (for epilepsy)
• Anat Baniel Method NeuroMovement
• Apollo Health / Dr. Dale Bredesen Protocol
• BrainHQ
• Deep Brain Stimulation (DBS)
• Designs for Strong Minds
• Dr. Antonucci Functional Neurology (Concussion & Neurorehab)
• Focused Ultrasound (FUS) / MR-Guided Focused Ultrasound (MRgFUS)
• Functional & Neuromuscular Electrical Stimulation (FES/NMES)
• Hyperbaric Oxygen Therapy (HBOT)
• Interactive Metronome (IM)
• John Pepper / Fast Walking Approach
• KAATSU / Blood Flow Restriction Training
• LearningRx
• LSVT LOUD
• Meditation / Mindfulness
• Medtronic Adaptive Deep Brain Stimulation (aDBS)
• Medtronic BrainSense
• Neurologic Music Therapy (NMT) / Rhythmic Auditory Stimulation (RAS)
• Photobiomodulation (PBM) / Professionally Delivered Red/Near-Infrared Light Therapy
• Rock Steady Boxing
• Specialized Neurorehabilitation Centers and Hospitals
• The Wahls Protocol
• Transcranial Direct Current Stimulation (tDCS)
• Transcranial Magnetic Stimulation (TMS)
• Vagus Nerve Stimulation (VNS)
• Virtual Reality (VR) Therapy

Related questions

These controlled question pages use the same stored condition and treatment relationships.

• What treatments are listed for Parkinson's Disease (PD) in the NPA database?

Recommended reading listed by NPA

These titles come from the current NPA condition record. Structured citation details are not yet available.

• Ending Parkinson's Disease: A Prescription for Action by Ray Dorsey, M.D., Todd Sherer, PhD, Michael S. Okun, M.D. & Bastiaan R. Bloem, M.D., PhD — A call to action from leading experts on preventing, treating, and ultimately ending Parkinson's disease.
• Living with Parkinson's Disease: A Complete Guide for Patients and Caregivers by Michael S. Okun, M.D. et al. — Practical advice from a leading neurologist on managing symptoms and maintaining quality of life with Parkinson's.
• Parkinson's Disease: A Complete Guide for Patients and Families by William J. Weiner, M.D., Lisa M. Shulman, M.D. & Anthony E. Lang, M.D. — A thorough, accessible medical guide covering symptoms, treatments, and daily living with Parkinson's.
• Soft-Wired: How the New Science of Brain Plasticity Can Change Your Life by Michael Merzenich, PhD — From a pioneering neuroscientist, practical principles for driving positive brain change at any age through targeted practice and experience.
• Spark: The Revolutionary New Science of Exercise and the Brain by John J. Ratey, M.D. with Eric Hagerman — Demonstrates how physical exercise powerfully boosts brain function, mood, learning, and resilience through neuroplastic mechanisms.
• The Brain That Changes Itself: Stories of Personal Triumph from the Frontiers of Brain Science by Norman Doidge — Landmark exploration of neuroplasticity featuring dramatic recoveries from stroke, brain injury, and other neurological challenges.
• The Brain's Way of Healing: Remarkable Discoveries and Recoveries from the Frontiers of Neuroplasticity by Norman Doidge — Shows how light, sound, vibration, and movement can awaken the brain's self-healing capacities after injury and illness.